Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7

specific

Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)

68

Centers

68

Active Trials

Cancer Funding

Top Centers for Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7(68)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
50.7
2
NCI Comprehensive
Active Research Program
50.7
3
NCI Comprehensive
Active Research Program
50.7
4
NCI Comprehensive
Active Research Program
50.7
5
NCI Comprehensive
Active Research Program
50.7
6
NCI Comprehensive
Active Research Program
50.7
7
NCI Comprehensive
Active Research Program
50.7
8
NCI Comprehensive
Active Research Program
50.7
9
NCI Comprehensive
Active Research Program
50.7
10
NCI Comprehensive
Active Research Program
50.7
11
NCI Comprehensive
Active Research Program
50.7
12
NCI Comprehensive
Active Research Program
50.7
13
NCI Comprehensive
Active Research Program
50.7
14
NCI Comprehensive
Active Research Program
50.7
15
NCI Comprehensive
Active Research Program
50.7
16
NCI Comprehensive
Active Research Program
50.7
17
NCI Comprehensive
Active Research Program
50.7
18
NCI Comprehensive
Active Research Program
50.7
19
NCI Comprehensive
Active Research Program
50.7
2050.7
21
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.7
22
NCI Comprehensive
Active Research Program
50.7
23
NCI Comprehensive
Active Research Program
50.7
24
NCI Comprehensive
Active Research Program
50.7
25
NCI Comprehensive
Active Research Program
50.7
26
NCI Comprehensive
Active Research Program
50.7
27
NCI Clinical
Active Research Program
50.7
28
NCI Comprehensive
Active Research Program
50.7
29
NCI Comprehensive
Active Research Program
50.7
30
NCI Comprehensive
Active Research Program
50.7
31
NCI Comprehensive
Active Research Program
50.7
32
NCI Comprehensive
Active Research Program
50.7
33
NCI Clinical
Active Research Program
50.7
34
NCI Comprehensive
Active Research Program
50.7
35
Active Research Program
50.7
36
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
50.7
37
NCI Comprehensive
Active Research Program
50.7
38
Active Research Program
50.7
39
Active Research Program
50.7
40
NCI Comprehensive
Active Research Program
50.7
41
NCI Comprehensive
Active Research Program
50.7
42
NCI Clinical
Active Research Program
50.7
43
NCI Comprehensive
Active Research Program
50.7
44
NCI Comprehensive
Active Research Program
50.7
45
NCI Comprehensive
Active Research Program
50.7
46
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.7
47
Active Research Program
50.7
48
NCI Clinical
Active Research Program
50.7
49
NCI Comprehensive
Active Research Program
50.7
50
Active Research Program
50.7
51
Active Research Program
50.7
5250.7
53
Active Research Program
50.7
54
Active Research Program
50.7
55
Active Research Program
50.7
56
Active Research Program
50.7
57
Active Research Program
50.7
58
Active Research Program
50.7
59
Active Research Program
50.7
60
Active Research Program
50.7
61
Active Research Program
50.7
6250.7
63
Active Research Program
50.7
64
Active Research Program
50.7
65
Active Research Program
50.7
66
Active Research Program
50.7
67
BC CancerVancouver, BC
Active Research Program
50.7
68
Active Research Program
50.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →